Vijaya diagnostics logs 25% yoy decline in PAT at Rs23.70 crore for Q4FY22; stock plunges ~4%

EBITDA margin for Q4 & FY22 were 44.10% and 41.20% respectively.

May 27, 2022 3:40 IST | India Infoline News Service
Vijaya Diagnostic Centre Limited, one of India’s leading integrated diagnostic chains, has announced its financial results for the quarter and twelve months ended March 31, 2022.

The company has reported a 23% yoy increase in revenue at Rs462.40 crore in FY22 as compared to Rs376.70 crore in FY21. For Q4FY22, the company reported growth of 4% yoy at Rs116.20 crore as against Rs112 crore in Q4FY21.

Company’s EBITDA for Q4FY22 was Rs47.90 crore as compared to Rs54.40 crore, down by 12% yoy. For FY22, EBITDA stood at Rs203.70 crore as against Rs166 crore in the previous financial year, a growth of 23% yoy.

PAT for the quarter under review stood at Rs23.70 crore, registering a decline of 25% yoy against Rs31.40 crore in Q4FY21. It logged growth of 30% yoy in PAT at Rs109.70 crore in FY22 as against Rs84.50 crore in FY21.

EBITDA margin for Q4 & FY22 were 44.10% and 41.20% respectively.

Vijaya Diagnostic ended at Rs381.35 down by Rs14.1 or 3.57% from its previous closing of Rs395.45 on the BSE. The scrip touched day's high and low of Rs405.65 and Rs376 respectively.

FREE Benefits Worth 5,000



Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity